Please assess the completion status of the following clinical trial:

Trial Title: Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically and/or cytologically proven NSCLC~* Unresectable disease~* Stage IIIA except T3N1M0 and IIIB which does not have disease extended to any contralateral hilar nodes, atelectasis of the entire lung or malignant pleural effusions~* A required radiation field of less than one half of one lung~* Measurable disease~* No previous chemotherapy or radiotherapy~* Age \>= 71~* Unable to receive cisplatin-based combination chemotherapy~* ECOG performance status (PS) of 0-2~* Adequate bone marrow, lung, hepatic, and renal function~* Written informed consent~Exclusion Criteria:~* Active infection, diarrhea, ileus, uncontrolled diabetes, myocardial infarction within three months, or severe other comorbidity~* Synchronous cancer or metachronous (within 5 years) malignancy~* Interstitial pneumonia or active lung fibrosis on chest X-ray~* Severe chronic obstructive pulmonary disease, chronic bronchitis, or bronchial asthma~* Pleural or pericardial effusion~* A history of severe hypersensitivity~* Mental disorder~* Judging of inappropriate condition for this study by physician

- Gender: ALL
- Minimum Age: 71 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Procedure/Surgery: A: Radiotherapy alone
- 2 (Type: EXPERIMENTAL): Drug: B: CBDCA and Radiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).